Background Most post-licensure vaccine pharmacovigilance in low-and middle-income
countries (LMICs) are passive reporting systems. These have limited utility for maternal …

Background: Pregnant women and neonates represent one of the most vulnerable groups,
especially in low-and middle-income countries (LMICs). A recent analysis reported that most …

Background There is an urgent need for active safety surveillance to monitor vaccine
exposure during pregnancy in low-and middle-income countries (LMICs). Existing maternal …

Introduction Since the establishment of the Global Alignment of Immunization Safety
Assessment in pregnancy (GAIA) case definitions in 2015, there has been an urgent need …

Although major reductions in maternal and child mortality were achieved in the Millennium
Development Goals era, progress must be accelerated to meet Sustainable Development …

Strengthening antenatal care as a platform for maternal immunization is a priority of the
World Health Organization (WHO). Systematic surveillance for adverse events following …

Background There is increasing evidence that maternal immunization has the potential to
improve health outcomes for both mothers and their babies. As a number of promising …

Introduction There is an urgent need to investigate the capabilities of active surveillance in
strengthening the development of pharmacovigilance (PV) systems in low-resource settings …

Background Most perinatal and neonatal deaths occur in low-and middle-income countries
(LMICs), yet, quality data on burden of adverse outcomes of pregnancy is limited in such …

Maternal vaccination is considered a key component of the antenatal care package for
improving maternal and child health. Low-and middle-income countries (LMICs) fall short of …